According to several sources, Shan Guohong will join BeiGene. Shan Guohong is currently the global senior vice president of Takeda Pharmaceuticals and the president of Takeda Pharmaceuticals China, and is about to leave. Shan Guohong is expected to replace Yin Min, who is under investigation by regulatory authorities, as the chief business officer of BeiGene Greater China, but Shan Guohong's job responsibilities are different from Yin Min's. The specific time when Shan Guohong will join BeiGene has not yet been confirmed, and BeiGene has not commented on Yicai's inquiries.